Be a Smart Investor
Tuesday, May 24, 2016
The value of M&A to pharma
John Rountree, managing partner at Novasecta, talks about whether or not the Bayer-Monsanto merger would create more or less innovation and value.
from Mergers and Acquisitions http://ift.tt/1YUi9w8
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment